Search research articles
Contact Us
Filters
Showing results (1-10 of 167) with videos related to
Page
of 17
Sort By:
Frontiers in Medicine
|
June 16, 2016
Genetic Influences on the Development of Fibrosis in Crohn's Disease
Bram Verstockt, Isabelle Cleynen
Expert Review of Gastroenterology & Hepatology
|
November 13, 2025
Recent developments in biomarker guided therapy for Crohn's disease
André Bargas, Joana Torres, Bram Verstockt
Current Opinion in Pharmacology
|
October 11, 2020
Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
Dahham Alsoud, Séverine Vermeire, Bram Verstockt
Expert Opinion on Therapeutic Targets
|
October 8, 2019
Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)
Sare Verstockt, Bram Verstockt, Séverine Vermeire
Current Research in Pharmacology and Drug Discovery
|
February 11, 2022
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
Dahham Alsoud, Séverine Vermeire, Bram Verstockt
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Genetics of inflammatory bowel disease: beyond NOD2
Maša Umićević Mirkov, Bram Verstockt, Isabelle Cleynen
Gastroenterology
|
January 7, 2022
How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?
Bram Verstockt, Miles Parkes, James C Lee
The Lancet. Gastroenterology & Hepatology
|
May 21, 2021
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Dahham Alsoud, Bram Verstockt, Claudio Fiocchi, et al.
Journal of Crohn'S & Colitis
|
April 8, 2024
Chronic Kidney Disease in Inflammatory Bowel Disease: a Systematic Review and Meta-analysis
Ward Zadora, Tommaso Innocenti, Bram Verstockt, et al.
Therapeutic Advances in Gastroenterology
|
June 18, 2019
New biologics and small molecules in inflammatory bowel disease: an update
João Sabino, Bram Verstockt, Séverine Vermeire, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 167) with videos related to
Sort By:
Page
of 17
Frontiers in Medicine
|
June 16, 2016
Genetic Influences on the Development of Fibrosis in Crohn's Disease
Bram Verstockt, Isabelle Cleynen
Expert Review of Gastroenterology & Hepatology
|
November 13, 2025
Recent developments in biomarker guided therapy for Crohn's disease
André Bargas, Joana Torres, Bram Verstockt
Current Opinion in Pharmacology
|
October 11, 2020
Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
Dahham Alsoud, Séverine Vermeire, Bram Verstockt
Expert Opinion on Therapeutic Targets
|
October 8, 2019
Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)
Sare Verstockt, Bram Verstockt, Séverine Vermeire
Current Research in Pharmacology and Drug Discovery
|
February 11, 2022
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
Dahham Alsoud, Séverine Vermeire, Bram Verstockt
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Genetics of inflammatory bowel disease: beyond NOD2
Maša Umićević Mirkov, Bram Verstockt, Isabelle Cleynen
Gastroenterology
|
January 7, 2022
How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?
Bram Verstockt, Miles Parkes, James C Lee
The Lancet. Gastroenterology & Hepatology
|
May 21, 2021
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Dahham Alsoud, Bram Verstockt, Claudio Fiocchi, et al.
Journal of Crohn'S & Colitis
|
April 8, 2024
Chronic Kidney Disease in Inflammatory Bowel Disease: a Systematic Review and Meta-analysis
Ward Zadora, Tommaso Innocenti, Bram Verstockt, et al.
Therapeutic Advances in Gastroenterology
|
June 18, 2019
New biologics and small molecules in inflammatory bowel disease: an update
João Sabino, Bram Verstockt, Séverine Vermeire, et al.
Page
of 17